18 results
PRE 14A
ABOS
Acumen Pharmaceuticals Inc
14 Apr 23
Preliminary proxy
4:33pm
for a Three-Year Term Expiring at the 2026 Annual Meeting
INFORMATION REGARDING THE BOARD OF DIRECTORS AND CORPORATE GOVERNANCE
Independence Of The Board … Of The Board Of Directors
Audit Committee
Compensation Committee
Nominating and Corporate Governance Committee
Stockholder Communications With The Board
8-K
EX-99.1
9os5l9pk79x02tm
14 Nov 22
Acumen Pharmaceuticals Reports Third Quarter 2022
4:10pm
DEF 14A
8cayj
27 Apr 22
Definitive proxy
5:03pm
10-K
y54h9eo1kyeqn6rubxy
28 Mar 22
Annual report
4:51pm
10-K
EX-10.3
ymwgg oye2de
28 Mar 22
Annual report
4:51pm
10-Q
x1yc3y ark8
16 Aug 21
Quarterly report
4:51pm
424B4
0iy74yz
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
uniyyu4k7kbinrwj
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
EX-10.2
9zdadpgpb3mumcqxy8m8
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
EX-10.3
1rb7tfn5pi9vmn9ngq
24 Jun 21
IPO registration (amended)
8:17am
S-1
tapnd4ni8
9 Jun 21
IPO registration
5:02pm
DRS/A
wlt8 9992cuy
14 May 21
Draft registration statement (amended)
12:00am
DRS
itmos0g6 l5j
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next